Needham & Company LLC Reiterates Buy Rating for Mereo BioPharma Group (NASDAQ:MREO)
Mereo BioPharma Group (NASDAQ:MREO – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a report issued on Wednesday,Benzinga reports. They currently have a $7.00 target price on the stock. Needham & Company LLC’s target price indicates a potential upside of 190.46% from the stock’s previous close. Several other […]
Mereo BioPharma Group (NASDAQ:MREO – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a report issued on Wednesday,Benzinga reports. They currently have a $7.00 target price on the stock. Needham & Company LLC’s target price indicates a potential upside of 190.46% from the stock’s previous close. Several other […]
